Eltrombopag and the Bcl-extra-large (xL) Pathway in Idiopathic Thrombocytopenic Purpura (ITP)

Clinical trial NCT00902018 · COMPLETED

Trial details

NCT number: NCT00902018
Sponsor: Weill Medical College of Cornell University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Immune Thrombocytopenia

Start date: 2009-01-01
Primary completion: 2015-09-07
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.